Beyfortus

Sanofi gets FDA untitled letter over Beyfortus promotional emails

The FDA called out Sanofi's characterization of Beyfortus as an RSV preventative, as opposed to its indication for RSV lower respiratory tract disease.

Zoey Becker Jul 22, 2026 2:42pm

Sanofi reprimanded for disparaging Pfizer’s RSV vaccine

Jul 22, 2026 6:27am

Sanofi teams up with Special Olympics Unified Football World Cup

Jul 15, 2026 8:05am

Merck seeks Enflonsia expansion to rival Sanofi, AZ's Beyfortus

Feb 19, 2026 10:40am

Sanofi sanctioned over CEO's 'bold claims' about Pfizer vaccine

Feb 3, 2026 9:40am

Sanofi shrugs off policy tumult as it predicts vaccine sales dip

Jan 29, 2026 11:42am